Free Trial
→ Why More Investors Are Using Family Trusts to Protect Their Wealth (From SmartAsset) (Ad)tc pixel Free SLRX Stock Alerts

Salarius Pharmaceuticals (SLRX) SEC Filings & 10K Form

Salarius Pharmaceuticals logo
$3.80 -0.01 (-0.26%)
Closing price 04:00 PM Eastern
Extended Trading
$3.92 +0.13 (+3.29%)
As of 07:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Salarius Pharmaceuticals SEC Filings

Export to Excel
DateFilerForm TypeView
09/26/2025
4:12 PM		Salarius Pharmaceuticals (Subject)
Form FWP
09/23/2025
4:27 PM		Salarius Pharmaceuticals (Filer)
Form S-1/A
09/18/2025
6:01 AM		Salarius Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/09/2025
7:04 AM		Salarius Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/27/2025
3:10 PM		Salarius Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/26/2025
4:29 PM		Salarius Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/26/2025
3:07 PM		Salarius Pharmaceuticals (Filer)
Form 8-K/A
08/22/2025
4:22 PM		Salarius Pharmaceuticals (Filer)
Form 424B5
08/22/2025
4:14 PM		Salarius Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/18/2025
7:33 AM		Salarius Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/15/2025
10:03 AM		Salarius Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/12/2025
4:27 PM		Salarius Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/07/2025
7:50 PM		Salarius Pharmaceuticals (Filer)
Form S-1/A
07/31/2025
10:08 AM		Salarius Pharmaceuticals (Filer)
Form S-1/A
07/21/2025
7:39 AM		Salarius Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/14/2025
7:33 AM		Salarius Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/08/2025
11:00 AM		Salarius Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/11/2025
7:38 AM		Salarius Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/27/2025
8:26 AM		Salarius Pharmaceuticals (Filer)
Form DEF 14A
05/27/2025
8:30 AM		Salarius Pharmaceuticals (Filer)
Form DEFA14A
05/15/2025
4:18 PM		Salarius Pharmaceuticals (Filer)
Form PRE 14A
03/28/2025
3:30 PM		Salarius Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/21/2025
3:30 PM		Salarius Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/11/2025
5:56 AM		Salarius Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/11/2025
5:00 AM		Salarius Pharmaceuticals (Filer)
Form 424B5
01/21/2025
7:01 AM		Salarius Pharmaceuticals (Filer)
Form S-1
Registration statement under Securities Act of 1933  
01/17/2025
4:17 PM		Salarius Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/13/2025
7:36 AM		Salarius Pharmaceuticals (Filer)
Form 424B3
01/13/2025
7:09 AM		Salarius Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/29/2024
11:15 PM		Salarius Pharmaceuticals (Filer)
Form EFFECT
12/27/2024
3:35 PM		Salarius Pharmaceuticals (Filer)
Form D
Notice of Exempt Offering of Securities 
12/23/2024
11:22 AM		Salarius Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/16/2024
5:12 AM		Salarius Pharmaceuticals (Filer)
Form S-1
Registration statement under Securities Act of 1933  
11/01/2024
4:05 PM		Salarius Pharmaceuticals (Filer)
Form DEFA14A
11/01/2024
4:04 PM		Salarius Pharmaceuticals (Filer)
Form DEF 14A
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:SLRX) was last updated on 9/29/2025 by MarketBeat.com Staff
From Our Partners
Trump’s national nightmare is here
Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...
Porter & Company | Sponsoredtc pixel
He Called Nvidia at $1.10. Now, He Says THIS Stock Will…
The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...
The Oxford Club | Sponsoredtc pixel
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsoredtc pixel
Capital Gains Tax Strategies for Seniors
Capital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...
SmartAsset | Sponsoredtc pixel
Out of 18,347 Cryptocurrencies... This is the ONLY One
The Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...
Crypto 101 Media | Sponsoredtc pixel
A New Way to Double Your Retirement Income?
Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...
Investors Alley | Sponsoredtc pixel
What The Silver Boom Could Mean For You…
AI, electric vehicles, and even global central banks are quietly fueling record demand for silver. This once-o...
Goldco Precious Metals | Sponsoredtc pixel
2013 Bitcoin miner reveals his trading system (free)
There are 18,347 cryptocurrencies in the market right now. 99% of them will fail. And trying to pick winner...
Crypto Swap Profits | Sponsoredtc pixel